Longevity & AgingSenescence and Short Telomeres Make IPF Lung Cells Far More Vulnerable to Injury
Idiopathic pulmonary fibrosis (IPF) is a deadly lung disease tied to aging lung lining cells. Researchers grew alveolar epithelial cells from patients with pulmonary fibrosis (mostly IPF) and from controls, then injured them with bleomycin. The patient cells had shorter telomeres at baseline and lost more telomere length after injury. They also showed stronger senescence and inflammation signals (p16, p21, IL-6, IL-36γ) and more keratin 17-positive cells stuck between cell types. Forcing telomere shortening by repeated passaging made the injury worse. The telomerase activator cycloastragenol and some senotherapeutics (iguratimod, rapamycin, resveratrol) reduced injury markers. The findings support senescence-linked telomere shortening as a driver of IPF vulnerability and offer a human-cell model for testing drugs. The work is preclinical.
